Neoadjuvant Chemotherapy Prior to Trimodality Therapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis
Year: 2025
Type: article
Language: en
Topic: Bladder and Urothelial Cancer Treatments
Authors and affiliations:
raw_author_name: Keiichiro Miyajima
raw_affiliation_strings: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
Division of Anatomy, Medical University of Vienna, Vienna, Austria
raw_author_name: Akihiro Matsukawa
raw_affiliation_strings: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
Division of Anatomy, Medical University of Vienna, Vienna, Austria
raw_author_name: Takafumi Yanagisawa
raw_affiliation_strings: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
raw_author_name: Marcin Miszczyk
raw_affiliation_strings: Collegium Medicum - Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
raw_author_name: Navid Roessler
raw_affiliation_strings: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
raw_author_name: Shota Inoue
raw_affiliation_strings: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
raw_author_name: Abdulrahman S. Alqahtani
raw_affiliation_strings: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Department of Urology, Ministry of Health, Second Health Cluster, Riyadh, Kingdom of Saudi Arabia
raw_author_name: Ahmed R. Alfarhan
raw_affiliation_strings: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Department of Urology, Prince Saud Bin Jalawi Hospital, Al Ahsa Health Cluster, Al Ahsa, Kingdom of Saudi Arabia
raw_author_name: Fumihiko Urabe
raw_affiliation_strings: Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
raw_author_name: Keiichiro Mori
raw_affiliation_strings: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
raw_author_name: Pierre I. Karakiewicz
raw_affiliation_strings: Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada
raw_author_name: Takahiro Kimura
raw_affiliation_strings: Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
raw_author_name: Shahrokh F. Shariat
raw_affiliation_strings: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Department of Urology, Semmelweis University, Budapest, Hungary
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA
Department of Urology, Weill Cornell Medical College, New York, NY, USA
Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan
Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria